Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
17.98
+0.22 (1.24%)
At close: Dec 5, 2025
Zhejiang Huahai Pharmaceutical Company Description
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally.
The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates.
It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals.
In addition, the company offers contract manufacturing and other services, as well as import and export trade services.
Further, it operates as a pharmaceutical company. Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.
Zhejiang Huahai Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1989 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 9,065 |
| CEO | Bao Hua Chen |
Contact Details
Address: Xunqiao Linhai, Zhejiang Province 317024 China | |
| Phone | 86 576 8501 0288 |
| Website | huahaipharm.com |
Stock Details
| Ticker Symbol | 600521 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001DL5 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Bao Hua Chen | GM, President and Director |
| Mei Zhang | Senior Vice President and Chief Financial Officer |
| Yong Hua Zhu | Vice President, Secretary of the Board and Director |
| Sijia Guo | Executive Vice President and Director |
| Yanhua Meng | Vice President |
| Bin He | Vice President |
| Lihong Lin | Vice President |
| Mi Xu | Vice President |
| Qi Mao Chen | Vice President |
| Bo Xu | Vice President |